Skip to main content
. 2018 Jan 12;11:737. doi: 10.3389/fnins.2017.00737

Table 1.

Clinical information on study subjects.

AMC PD
Age (yrs) 64.2 ± 3.9 65 ± 5.05
N (M/F) 5 (2/3) 4 (2/2)
Time since diagnosis (yrs) NA 7.83 ± 3.34
UPDRS (III) score NA 8.1 ± 6.45
Daily L-Dopa (mg) NA 456 ± 180

Values are expressed as mean ± SD. All PD patients were taking levodopa with adjunctive dopamine agonist therapy. AMC subjects were not related to the PD subjects. One AMC subject cohabited with a PD subject.